HWPC(SH:688799) Zheng Quan Zhi Xing·2025-07-27 16:13Core Viewpoint - The major shareholder Xu Xiaoqiang of Hunan Warner Pharmaceutical Co., Ltd. plans to reduce his shareholding by up to 1,300,000 shares, accounting for approximately 0.9899% of the company's total share capital due to personal financial needs [1][2] Shareholding Structure - As of the announcement date, Xu Yan holds 18,480,000 shares, representing 14.0725% of the total share capital, while Xu Yuehan holds no shares [1][3] - Xu Xiaoqiang's current shareholding includes 1,407,800 shares obtained before the IPO and 563,120 shares acquired through capital reserve conversion [2] Reduction Plan Details - The reduction period is set from August 19, 2025, to November 18, 2025, with a maximum of 1,300,000 shares to be sold through block trading [2][4] - The plan allows for adjustments in the number of shares to be reduced if there are changes in the company's share structure during the reduction period [2][4] Compliance and Commitments - The major shareholders have made commitments regarding share transfer restrictions, including a 12-month lock-up period post-IPO, during which they cannot transfer or manage their shares [5][6] - The company assures that the reduction plan complies with relevant laws and regulations, and will not significantly impact the company's governance or ongoing operations [9]